Anticoagulants Market Size worth around US $39 billion by 2026: Acumen Research and Consulting Print E-mail
Friday, 15 March 2019 00:28


LOS ANGELES, March 15, 2019 (GLOBE NEWSWIRE) -- The international Anticoagulants market is prophesied to grow with 7.9% CAGR between the year 2018 to 2026 and the market is expected to hit the value of USD 39billion by 2026.

Free Download Sample Report Pages For Better [email protected]

Increasing surgeries and heart related diseases is foreseen to drive the demand for anticoagulants over forecast period. Other factors such as, the global increase in geriatric population, increasing disposable incomes, and rise population in geriatric population expected to fuel the demand for anticoagulants and hence drive the market growth. The anticoagulants are used for preventing the clot formation in the human body and are foreseen to be key factor driving the market growth. Also, anticoagulants can prevent the enlargement of the existing clots in the vein or arteries so that the health hazards are reduced to significant level.In addition, anticoagulants plays an outstanding role while performing the surgery.Such properties of Anticoagulants are making them one of the irreplaceable part in the operational areas associated with the deep venous thrombosis (DVT), pulmonary embolism (PE), angina, dialysis, atrial fibrillation (AF), thrombocytopenia, and myocardial infarction.

Growing need for controlling the diseases related to kidney and rise in number of cardiovascular disease patients is expected to propel the market growth over forecast period. In addition to this, rise in obesity patient and hence a related disorder is another factor which is ultimately boosting the adoption of Anticoagulants in the healthcare areas and hence driving the market growth. The anticoagulant are drugs which functions as blood thinners. These drugs are majorly used for high risk of blood clots in various medical conditions. The importance of anticoagulants in preventing the clot formation in the human body is foreseen to be prime factor driving the market growth.

View Detail Information With Complete [email protected]

The global anticoagulants market is segmented intoroute of administration - Oral, and Injectable. On the basis of drug class, the anticoagulants market is segmented into Factor XA Inhibitors (NOAC/DOAC), Heparins, Direct Thrombin Inhibitors, Vitamin K Antagonists. On the basis of Indication, the global anticoagulants market is segmented into Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Atrial Fibrillation and Heart Attack. On the basis of distribution channel the market is divided into hospital pharmacies, retail pharmacies, and online pharmacies. On the basis of region the global Anticoagulants market is bifurcated into Europe, Latin America, North America, Middle East & Africa, and Asia Pacific.

North America was the dominant region in terms of demand and consumption of anticoagulants in 2018 and similar trend is expected to continue over forecast period. The rise in coagulation disease across different age groups and increasing surgery operations for knee and hips majorly are some of the prime factors boosting the demand for anticoagulants in this region. In addition to this, dense presence of anticoagulants manufacturers is another factor which is making North America a leader in this market.  The increasing interference of healthcare organisations and control authorities present in this region is resulting into availability of more advanced and improved anticoagulants in market patients.

Browse All official Market Research Reports Press [email protected]

Explore Our Market [email protected]

The organizations such as WHO (World Health Organization), American Heart Association (AHA), American College of Cardiology (ACC) and Heart Rhythm Society (HRS), and others are increasing focusing on research and development in the anticoagulants. The research is primarily aimed at lowering the other side effects of the anticoagulants as there is lack of awareness about the side effects of oral anticoagulants. The organizations are coming up with new guidelines for the industry to maintain a standardised content of the anticoagulants and lessen the side effects and life hazards.

The Asia Pacific region is expected to be the fastest growing region in terms of demand of anticoagulants owing to increasing disposable income and rise in health issues in this region is fuelling the market growth. The increasing kidney diseases, heart diseases, strokes, and others is increasing need for using anticoagulants as a thinner agent for human blood for maintaining a required flow and such factor are making the anticoagulant an important part in healthcare area.

The players contributing in the global Anticoagulants market are Johnson & Johnson Services, Inc.,Bayer Healthcare, Daiichi Sankyo Company Limited, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company,Pfizer, Inc., and Sanofi.

INQUIRY BEFORE [email protected]

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report –

Would like to place an order or any question, please feel free to contact at [email protected] | +1 407 915 4157

For Latest Update Follow Us:

Browse More Press Releases:

Primary Logo

"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit!! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!